Top 10 Companies in the Adhesive Materials for Medical Devices Market (2026): Market Leaders Powering Global Healthcare

MARKET INSIGHTS

Global adhesive materials for medical devices market size was valued at USD 19.32 billion in 2024. The market is projected to grow from USD 21.15 billion in 2025 to USD 48.52 billion by 2032, exhibiting a CAGR of 11.2% during the forecast period.

Adhesive materials for medical devices are specialized formulations designed for bonding components in healthcare applications. These materials include synthetic polymers such as acrylics, silicones, and polyurethanes, as well as natural bioadhesives derived from substances like chitosan. They must meet stringent biocompatibility standards while providing properties such as flexibility, sterilization resistance, and controlled adhesion strength.

The market growth is driven by increasing demand for minimally invasive surgical procedures and wearable medical devices, which require advanced bonding solutions. While North America currently dominates the market with 38% revenue share, Asia‑Pacific is emerging as the fastest‑growing region due to expanding healthcare infrastructure. Recent innovations include smart adhesives with sensing capabilities, though regulatory challenges remain a key restraint for new product development.

Adhesive Materials for Medical Devices Market – View in Detailed Research Report

Top 10 Companies in the Adhesive Materials for Medical Devices Market

1. 3M Company

Headquarters: St. Paul, Minnesota, USA
Key Offering: Medical‑grade adhesives for wound care, surgical drapes, and wearable devices

3M’s diversified portfolio positions it as the market leader, with a strong focus on research into advanced wound closure technologies. The acquisition of Acelity in 2019 expanded its capabilities in hydrogel and silicone‑based adhesives that provide superior conformability and infection‑blocking properties.

Sustainability & Growth Initiatives: 3M is investing in bio‑based adhesive formulations that reduce reliance on petrochemicals and are compatible with terminal sterilization. The company’s global R&D network is driving next‑generation light‑curable adhesives that can be applied on demand in surgical theatres.

• Global footprint with >200 manufacturing sites
• Annual R&D spend > USD 1.5 billion
• Leading share in disposable adhesive markets

2. Henkel AG & Co. KGaA

Headquarters: Düsseldorf, Germany
Key Offering: Loctite MED series for orthopedic implants and medical devices

Henkel’s Loctite MED line has experienced 27% year‑on‑year growth since 2022, driven by a focus on high‑strength, biocompatible adhesives for implantable devices. The company’s strategic partnership with NuSil has enhanced its silicone‑based solutions for implantable and reusable devices.

Sustainability & Growth Initiatives: Henkel is expanding its bio‑based adhesive portfolio and has set a target to source 30% of its raw materials from renewable streams by 2030.

• Strong presence in Europe and Asia‑Pacific
• Robust collaboration with medical device OEMs
• Investment in additive manufacturing of adhesive components

3. H.B. Fuller Company

Headquarters: New Jersey, USA
Key Offering: Silicone‑based adhesives for implantable and reusable medical devices

HB Fuller’s partnership with NuSil in 2023 has positioned it at the forefront of high‑performance silicone adhesives, particularly for devices requiring long‑term biocompatibility and sterilization resilience.

Sustainability & Growth Initiatives: The company is developing eco‑friendly pressure‑sensitive adhesives that reduce volatile organic compound emissions during manufacturing.

• Global distribution network spanning 60+ countries
• Focus on modular adhesive solutions for surgical instruments
• Active R&D in bio‑resorbable adhesive chemistries

4. Dow Chemical Company

Headquarters: Midland, Michigan, USA
Key Offering: Specialty silicone and polyurethanes for medical devices

Dow’s recent $450 million R&D investment in bio‑based adhesives underscores its commitment to sustainable materials that meet the strictest biocompatibility standards.

Sustainability & Growth Initiatives: Dow is accelerating the transition to low‑carbon adhesive chemistries and expanding its portfolio of antimicrobial and antimicrobial‑free formulations.

• Large portfolio of specialty resins
• Strategic alliances with leading medical device manufacturers
• Investment in digital manufacturing for adhesive components

5. Scapa Group

Headquarters: Hamburg, Germany
Key Offering: High‑performance medical adhesives for implantable and reusable devices

Scapa’s focus on precision engineering and biocompatibility has secured a strong position in the European market, particularly in orthopedics and cardiovascular devices.

Sustainability & Growth Initiatives: The group is exploring plant‑derived polymer backbones to reduce environmental impact while maintaining adhesive strength.

• Strong OEM relationships across Europe
• Investment in green chemistry initiatives
• Continuous improvement in sterilization‑resistant formulations

6. Elkem Silicones

Headquarters: Oslo, Norway
Key Offering: Advanced silicone adhesives for medical devices and wearables

Elkem’s silicone solutions are prized for their flexibility and long‑term stability under sterilization conditions, making them ideal for wearable monitoring devices.

Sustainability & Growth Initiatives: The company is developing bio‑based silicone blends that reduce fossil‑fuel dependence and improve end‑of‑life recyclability.

• Strong presence in Scandinavia and North America
• Robust R&D in silicone chemistry
• Partnerships with wearable device manufacturers

7. Polymer Science, Inc.

Headquarters: New Jersey, USA
Key Offering: Custom polymer adhesives for medical implants and disposable devices

Polymer Science offers tailored adhesive solutions that balance mechanical strength with biocompatibility, serving a wide range of medical device manufacturers.

Sustainability & Growth Initiatives: The company is investing in recyclable polymer platforms and exploring additive manufacturing techniques to reduce waste.

• Customizable adhesive formulations
• Strong focus on regulatory compliance
• Active collaboration with academic research labs

8. Adhezion Biomedical

Headquarters: New Jersey, USA
Key Offering: Bio‑resorbable adhesives for temporary medical applications

Adhezion’s portfolio includes degradable adhesives that provide reliable bonding during the critical post‑operative period before safely degrading within the body.

Sustainability & Growth Initiatives: The firm is advancing timed‑degradation chemistries that align with specific clinical timelines, reducing the need for surgical retrieval.

• Focus on orthopedic and drug‑eluting implants
• Partnerships with leading hospitals for clinical trials
• Investment in precision synthesis of biodegradable polymers

9. DuPont de Nemours, Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Medical‑grade cyanoacrylates and specialty adhesives

DuPont’s launch of eight new cyanoacrylate formulations in Q1 2024 demonstrates its commitment to expanding the adhesive portfolio for both internal and external applications.

Sustainability & Growth Initiatives: The company is exploring green solvent alternatives and improving the energy efficiency of adhesive manufacturing processes.

• Strong global distribution network
• Continuous innovation in fast‑setting adhesives
• Investment in sustainability reporting and carbon footprint reduction

10. Dymax Corporation

Headquarters: New Jersey, USA
Key Offering: UV‑curable adhesives for minimally invasive surgical devices

Dymax’s UV‑curable solutions have driven a 32% revenue growth in Asia‑Pacific, enabling rapid on‑site application of high‑strength adhesives in complex surgical environments.

Sustainability & Growth Initiatives: The company is developing low‑VOC UV‑curable formulations and expanding its presence in emerging markets through local manufacturing agreements.

• Rapid curing technology for surgical use
• Strong focus on regulatory compliance in emerging regions
• Investment in local production facilities

Adhesive Materials for Medical Devices Market – View in Detailed Research Report

Adhesive Materials for Medical Devices Market – View in Detailed Research Report

Market Outlook (2025‑2034)

The market is expected to expand from USD 21.15 B in 2025 to USD 48.52 B by 2034, reflecting a sustained demand for advanced bonding solutions across minimally invasive procedures, wearable devices, and disposable medical products. The Asia‑Pacific region will likely lead growth due to rapid healthcare infrastructure development and a shift toward biocompatible, natural adhesives.

Future Trends

• Smart adhesives that incorporate sensing capabilities for real‑time monitoring of wound healing and implant integration.
• Bio‑resorbable adhesives designed for temporary fixation in orthopedic and cardiovascular applications, reducing the need for secondary surgeries.
• Wearable‑device adhesives that combine breathability, hypo‑allergenic properties, and long‑term skin compliance to support continuous patient monitoring.
• Green chemistry initiatives that focus on renewable raw materials, reduced VOC emissions, and end‑of‑life recyclability.
• Integration of additive manufacturing and digital twins to accelerate adhesive formulation and validation cycles.